Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $95,093 | 33 | 91.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,184 | 3 | 4.0% |
| Travel and Lodging | $3,814 | 14 | 3.7% |
| Food and Beverage | $747.79 | 17 | 0.7% |
| Grant | $200.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Greenwich Biosciences, Inc. | $37,750 | 14 | $0 (2021) |
| EMD Serono, Inc. | $13,166 | 11 | $0 (2019) |
| Intersect ENT, Inc. | $7,600 | 1 | $0 (2017) |
| VERTEX PHARMACEUTICALS INCORPORATED | $6,810 | 10 | $0 (2019) |
| EKOS Corporation | $4,950 | 1 | $0 (2018) |
| PneumRx, Inc | $4,800 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $4,558 | 5 | $0 (2019) |
| Pear Therapeutics (US), Inc. | $4,200 | 1 | $0 (2022) |
| Otonomy, Inc. | $3,460 | 5 | $0 (2017) |
| ABBVIE INC. | $3,286 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,750 | 1 | Ferring Pharmaceuticals Inc. ($2,750) |
| 2022 | $9,986 | 5 | Pear Therapeutics (US), Inc. ($4,200) |
| 2021 | $11,500 | 6 | Greenwich Biosciences, Inc. ($11,500) |
| 2020 | $28,050 | 9 | Greenwich Biosciences, Inc. ($26,250) |
| 2019 | $26,759 | 22 | EMD Serono, Inc. ($12,365) |
| 2018 | $10,551 | 8 | EKOS Corporation ($4,950) |
| 2017 | $14,443 | 17 | Intersect ENT, Inc. ($7,600) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2022 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 04/15/2022 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| 04/15/2022 | AbbVie Inc. | — | Travel and Lodging | Cash or cash equivalent | $80.48 | General |
| 04/15/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $55.98 | General |
| 03/17/2022 | Pear Therapeutics (US), Inc. | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 08/31/2021 | Greenwich Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 07/06/2021 | Greenwich Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 05/21/2021 | Greenwich Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/19/2021 | Greenwich Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 03/08/2021 | Greenwich Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 01/12/2021 | Greenwich Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 12/15/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: Neurology | ||||||
| 11/24/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Neurology | ||||||
| 10/19/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Neurology | ||||||
| 09/21/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 08/24/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 07/21/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Neurology | ||||||
| 06/22/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 05/22/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Neurology | ||||||
| 05/06/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: GERD | ||||||
| 07/16/2019 | Allergan Inc. | — | Consulting Fee | Cash or cash equivalent | $3,015.00 | General |
| 07/16/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $10.59 | General |
| 06/12/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $32.00 | General |
| 06/12/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $30.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 90 | 184 | $29,691 | $10,926 |
| 2022 | 4 | 118 | 221 | $40,218 | $14,853 |
| 2021 | 2 | 69 | 138 | $25,842 | $9,858 |
| 2020 | 3 | 68 | 99 | $8,834 | $6,554 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 29 | 58 | $9,802 | $3,368 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 25 | $7,225 | $2,909 | 40.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 28 | 73 | $7,008 | $2,432 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 28 | $5,656 | $2,218 | 39.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 36 | 74 | $12,506 | $4,568 | 36.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 33 | 81 | $13,689 | $4,425 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 25 | $7,225 | $3,011 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 27 | $5,454 | $2,303 | 42.2% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 12 | 14 | $1,344 | $546.70 | 40.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 39 | 98 | $16,562 | $6,085 | 36.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 21 | $6,069 | $2,574 | 42.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 17 | 19 | $3,211 | $1,199 | 37.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 36 | 67 | $5,432 | $4,180 | 77.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 18 | $3,110 | $2,191 | 70.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 14 | $291.91 | $183.15 | 62.7% |
About Dr. Wade Aubry, M.D
Dr. Wade Aubry, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447265814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wade Aubry, M.D has received a total of $104,039 in payments from pharmaceutical and medical device companies, with $2,750 received in 2023. These payments were reported across 68 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($95,093).
As a Medicare-enrolled provider, Aubry has provided services to 345 Medicare beneficiaries, totaling 642 services with total Medicare billing of $42,191. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location San Francisco, CA
- Active Since 07/31/2006
- Last Updated 01/14/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1447265814
Products in Payments
- Epidiolex (Drug) $26,250
- Bavencio (Biological) $12,831
- EKOSONIC (Device) $4,950
- PNEUMRX COILS (Device) $4,800
- BEOVU (Drug) $3,990
- OTIPRIO (Drug) $3,460
- REBYOTA (Biological) $2,750
- ESOPHYX (Device) $1,800
- Nucleus (Device) $700.00
- Spiration Valve System (Device) $700.00
- AFINITOR (Drug) $568.00
- GENERAL - STENTS (Device) $200.00
- i-FACTOR Putty (Device) $17.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in San Francisco
Cheng-Yang Tuan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $672,998
Dr. Nancy Bohannon, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $265,062
Lewis Blevins, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $158,184
Dr. Jennifer Perkins, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $84,954
Dr. Daniel Bikle, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23,160
Dr. Eric Buxton, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $10,839